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products from biotechnology research are beginning to emerge into the
con^ercial market. However, there has been a long gestation period which
followed the investor fervor associated with the promise of new products from
biotechnology and the spawning of many small biotech research firms to
capitalize on these new technologies. Biotechnology in practice is typically
considered to include not only genetic engineering, involving recombinant DNA
procedures, but some of the older and closely related tools of cell culture,
plant regeneration, monoclonal antibodies, embryo transfer, and bioprocess
engineering ^Agricultural Biotechnolo^= Str^^
nn^^etitiveness. 1987). ll^ese are extensions of the age-old techniques of
plant and animal breeding and selection that work with the entire organism;
the effort is now with individual genes within the organism (Walbot. 1987).
in 1985. responding to congressional interests, the Office of Technology
Assessment COXA) studied emerging technologies (including biotechnology) using
aDelphi approach with 300 scientists to identify the nature of technological
change, its timing, and its impact on the structure of agriculture
(OTA 1986). The OTA study, two Food and Drug Administration (FDA) surveys on
emerging veterinary products and food biotechnology (FDA. 1986. 1988). and the
university of California survey of biotechnology companies in 1987-88 reported
here suggest that the biotech products that have reached public attention, and
the very few in the commercial market, are only the tip of an ice g
number of products will be reaching the market place in the next five years.
and the volume will greatly expand in the late 1990s.
During October 1987 - February 1988. research or product development
managers in 2A leading companies involved in agricultural biotechnology
research or product development were interviewed in a personal visit or by
telephone. Each survey respondent was asked to identify (D the new
biotechnology products likely to enter the market place for use in plant or
animal agricultural production, or in the food processing industry in the next
decade, (2) the approximate time when these new products will enter the
market, and (3) the application in which the products will first be used. The
responses, supplemented by recent biotechnology literature and interviews with
academic biotechnologists, provide the basis for the biotechnology forecasts
presented here, (For more detail, see Hayenga, 1988). The implications of
the likely developments in biotechnology for the agribusiness sector are then
explored.
BIOTECHNOLOGY INNOVATIONS QH THE HORIZON
Currently, there are relatively few products or processes utilizing
recombinant DNA technology or less sophisticated biotechnology being marketed
in the food and agricultural sector. Among the most noteworthy now being
marketed are embryo transplants; microbial soil, silage and hay inoculants;
numerous fermentation processes and products involving yeast or other
cultures; biopesticides; the first recombinant animal vaccines; monoclonal
antibodies for diagnostic uses; and a genetically engineered enzjnne in corn
syrup production.
During the next five years, a large number of products from biotechnology
will enter the agriculture or food processing market. Most are now in or
nearing the field-testing stage or being subjected to a regulatory clearance
process, if required. The bulk of these products will come from cell culture
and cloning, or from other procedures short of genetic engineering (to avoid
the regulatory hurdles and costs imposed on genetic engineered products).
But a number of products from genetic engineering are also likely to enter the
market, especially transgenic plants and products derived from transgenic
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bacteria. In addition, some offshoots from human medical research on cancer.
aids, and the h^an in^unity system may be applied to agricultural problems.
We will focus initially on a few product areas with relatively large economic
importance where biotech innovations are likely to emerge on the market in the
next few years.
gpOHTH PROMOTAKTS
Several major chemical and pharmaceutical companies have had growth
promotants for dairy cattle and swine in the field-testing stage of
development for several years. Bovine somatotropin (BST). or dairy growth
hormone, has been a subject of controversy among dairymen, legislators, and
consumer groups. BST was identified over 50 years ago, but production
possible on ..co^nercial scale until recently when the growth hormone gene was
inserted into bacteria which could reproduce it in large quantities. Original
estimates of a 3.0 to 40 percent increase in milk production per cow are now
scaled down to a more realistic figure of 10 to 15 percent. Still, there are
concerns about dislocation of small dairy farmers. There are also fears about
negative consumer reaction to hormones in milk-though there should not be any
health issues with this type of hormone. Current industry estimates of likely
FDA approval are 1990 or 1991.
Potentially more important is the porcine somatotropin (PST). This new
product could lead to some growth rate improvements in market hogs, and to
major improvements in carcass fat content (-1/3). lean content (+1/7) and feed
use per pound of gain (-1/A). The prospect of significantly improved product
quality combined with lower production costs from these growth promotants
(produced using transgenic bacteria) could begin to be realized by 1989 or
1990.. The impact on the position of pork versus competing meats could be
significant, resulting in major structural shifts in the livestock and meat
sector. Two companies have plants for commercial production of PST built or
under construction.
BIOLOGICAL CONTROL AGENTS
Biological control agents (e.g.,. bacteria, viruses, fungi) often can be
used as alternatives to chemicals in agriculture. As the public concerns
about the effects of agricultural chemicals increase or re-registration costs
for "old" chemicals lead to their discontinuation, biotech and chemical
companies expect that biological controls will be in greater demand. Targeted
"pests" may be weeds, insects, nematodes, fungi, viruses, or bacterial
infestations (i.e., competing biological systems) which adversely affect the
productivity of agricultural crops.
Biological control may also be used against competing organisms not
conventionally viewed as pests. The goal is to displace the organism with an
adverse characteristic, such as the bacteria which promote ice crystal
formation on plants.
The range of biological control agents is potentially quite broad, and is
one of the primary focal points of agricultural product development in the
biotech industry. Progress is being made in identifying a broader variety of
possible control agents (e.g., more natural toxins for plant pests) and
improving their potency, to make them competitive -with some chemical
alternatives, or at least good second-best substitutes if and when certain
chemicals are no longer available.
Currently, biopesticides for insect control are likely candidates for new
product introductions in the next few years. Products using the Bt toxin
appear likely for forestry crops, targeting the gypsy moth and the spruce bud
worm, and for some large commercial agricultural crops like potatoes (potato
beetle) and corn (corn borer). In addition, plant fungal diseases, difficult
to control with current technology, are the focus of several new biological
control products likely to be introduced as early as 1988. Researchers have
been screening soil bacteria to find those with significant anti-fungal
activity. These can be reproduced and used in their natural form, though
efficiency and environmental survivability may vary, or the genes contributing
anti-fungal activity can be identified and used in genetically modifying soil
bacteria. Products aimed at cotton seedling and vegetable seedling diseases
are likely to be available in the next year or two. New products for fungal
diseases in several vegetable crops, fruit crops, and wheat are expected in
the early 1990s, and a corn fungal control product is likely within the next
five years.
Other biological controls use microbial competitors designed to compete
with harmful microbes or serve as pathogens for undesirables like weeds.
During the next five years, the controversial ice-minus bacteria should become
commercially available, possibly as early as 1991. Fruit and berry crops are
likely early commercial applications, thereby escaping crop loss associated
with freezing temperatures during the critical blossoming period.
Strawberries, almonds, cherries, peaches, and pears are the first crops likely
to have microbial sprays to provide less susceptibility to frost; grapes,
coffee, and other frost-sensitive crops will have similar products by the mid
1990s.
TRANSGENIC CROPS
Amajor class of genetic engineering products likely to emerge in the
next five years is the transgenic agricultural crop. The first such major
biotechnology breakthrough used E. Coli bacteria to produce desired plasmids,
and introduced them into a modified Agrobacteri™ soil bacteria to transfer
agriculturally useful genes into plants. Many plants, are receptive to this
method of genetic transmission, including tomato, potato, petunia, tobacco,
carrot, poplar, celery, alfalfa, lettuce, flax, oilseed rape, sugarbeet. and
asparagus. However, cereals and other monocots are nn.ch less amenable to this
method. in particular, the task of regenerating the cells and producing the
plants, is more difficult. This difference in ease of engineering and
reproduction is a primary determinant of which crops will be in the first or
second generations of genetic-engineered agricultural crops (Rogers. 1987).
Several major agricultural chemical or biotechnology companies are field
testing plants genetically engineered for herbicide resistance and insect
resistance, while more limited work involves viral resistance and fungal
resistance. The crop focus initially has been on simpler plants whose genetic
structures were among the first to be mapped. These are typically viewed as
prototypes for more complex, but commercially important crops, yet unmapped.
The primary investment in research and field testing of transgenic
agricultural crops has been with tobacco, tomatoes, potatoes, and canola
Crapeseed) . These may begin to emerge on the market in 1992 or 1993.
Meanwhile, crops like corn, wheat, soybeans, and cotton have been on the back
burner. However, recent developments in genetic engineering technology,
including microinjection for DNA entry through cell walls, and improvements in
plant regeneration techniques make grasses, like corn and wheat, good
candidates for progress in the mid to late 1990s.
Genes which give plants resistance to several major classes of herbicides
have been identified. Several major chemical companies and biotech companies,
or joint ventures between chemical and biotech companies, are actively
involved in developing herbicide resistant crops. Tomatoes resistant to
gl3T>hosphates, sulfonylurea, or bromoxinil are undergoing field tests in 1988,
as are rapeseed (canola) and tobacco for some of the same herbicides.
Alfalfa, corn, and wheat are also candidates for relatively early application
of transgenic herbicide resistance. In addition, tissue culture techniques
have been used to develop strains of corn which are resistant to a major
herbicide.^ Recently, a genetic engineered herbicide tolerant soybean has
been patented.
Insect resistance involving Bt gene transfers has been field-tested in
tobacco and tomatoes already, so the market entry could be within four to six
years. Other genetically engineered crops such as rapeseed, cotton, and
potatoes, will follow. Natural toxins will also be exploited against other
plant predators. These toxins t5^ically have quite specific target insects,
so the use of chemicals or biopesticides may still be necessary to control
other insects not affected by that toxin. Thus there could be displacement of
some, but not all chemical insecticides until broader spectrum coverage is
achieved by multi-toxin gene transfers into commercial crop varieties.
Virus resistant plants have also been field tested in tomatoes. While
viruses have not been considered a major problem in many commercial crops,
significant yield increases for tomatoes were observed in Monsanto's 1987
field test of virus resistance (Rogers, 1987). Tomatoes and potatoes, where
virus problems are important, are potential early market transgenic crops with
virus resistance.
^For an excellent discussion of genetically engineered crop resistance,
see Giaquinta, 1986.
VALUE-ADDED CONSUMER AND PROCESSING PRODUCT CHARACTERISTICS
During the next five years, a relatively small number of products will
emerge from the biotech research pipeline which will change the
characteristics of the ultimate consumer food product, or the product being
further processed. Most of these will be products of tissue culture or
related techniques, rather than genetic engineering. In some cases, natural
components of foods can be isolated and cloned into a producing organism,
possibly a plant or, more likely, a bacteria or yeast. Then, fermentation
processes can produce large quantities of these natural components. In
other cases, plant cells with desired characteristics can be cultured to
rapidly reproduce more biochemically complex flavors or other characteristics
which reflect more fully the essence of the natural product.
In addition to food ingredients and new food products with improved
consumer or processing characteristics, new industrial or pharmaceutical
products may be forthcoming from the plant or microbial production process.
The somatotropins for pork production are an excellent example of a
fermentation product to be sold by animal health products companies, causing
consumer pork products to be dramatically lower in fat content.
Drawing from our industry survey, the 1988 FDA survey, and an excellent
status report on food biotechnology by an Institute of Food Technology expert
panel (Food Technology, 1988), it appears that the most significant areas of
progress in food processing are likely to be in enzyme technology and in
fermentation products and processes, though some agronomic improvements in
plant characteristics important for processing or to the consumer will reach
the market.
VALUE-ADDED PLANT CHARACTERISTICS
Several biotech companies have been developing "higher solids" tomatoes,
potatoes, and onions to reduce the tonnage processed per unit of output, and
related energy and waste treatment expense. These products usually are based
on standard genetic selection procedures, though genetic engineering is also
being explored to achieve the same goals.
At least one company has test-marketed new strains of carrots, celery,
and other vegetables which have more crispness, sweetness, or less
stringiness, etc. In the research pipeline, there are a number of products
like fluffier popcorn, perhaps with its own salty taste and better flavors,
seedless peppers, pineapple with novel colors or flavors, and naturally low
caffeine coffees developed using tissue culture methods. Bruise tolerance and
ripening or softening characteristics are areas where progress is being made
in some products, where initial market entries within five years are a
possibility. A few companies are nearing commercial development of alfalfa
with increased leaf storage protein (for livestock feed). Others are working
on oilseeds (like rapeseed or sunflower) with a higher processing yield of oil
or more desirable fatty acid composition (e.g., high oleic acid) for either
improved nutritional properties (degree of saturation) or shelf-life
enhancement (of the oil itself or the food products using it).
Genetic engineering is being used to introduce color genes from one
flower to others. For example, genes conferring blue colors to petunias can
be transferred to roses, carnations, or chrysanthemums to provide some unique
ornamentals in the next few years. And genetic introduction of a human growth
hormone into tobacco could result in an agricultural plant being used as a
factory to produce pharmaceutical products.
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Cell culture production techniques are being used to generate natural
vanilla, grape, and strawberry flavors fro™ cells of those plants, with other
fruit or berry flavors also possibilities in the next few years. Product
yields are often many times greater than found in the native plant, making
this apotentially conmercial source of high value natural products providing
desirable flavors, colors, preservatives, or nutritional supplements (Food
Technologyt 1988).
Textural changes in food products utilizing bioengineering techniques
provide the basis for some potential new products in the next few years.
Hydrolyzing proteins or mechanical means of protein structure modification can
bring about textural changes which can greatly change perceived food
characteristics. For example, the recently announced Simplesse low-calorie
fat substitute (restructured milk and egg protein) could potentially reach
market in dairy products in the next few years.
FOnP-PRQCESSING ADVANCES
Food processing advances coming from biotechnology are more likely to
go unnoticed or be of little concern to the general public, since they will
be developed at the processing level without obvious direct impact on
consumers. During the next five years, advances in enzyme technology and
related processing efficiency are reportedly the potentially most ijnportant
biotechnology developments. Enzymes are important in the production of
high-fructose corn syrups, brewing, baking, dairy processing, and meat
tenderization. Recently Pfizer has developed a genetically engineered enzyme
(rennet) which can be produced by fermentation rather than by extracting it
from byproducts of beef packing, significantly improving its availability for
cheese makers. Enzyme immobilization by attaching an enzyme to a stable
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supporting material is likely to significantly enhance enzyme viability in
more efficient continuous production processes. Enzymes such as lipases for
fats or proteases for proteins can be made to function in processing
environments that previously were inhospitable; now these more complex fat or
protein molecules can be broken into components, with different
characteristics (e.g., to enhance or eliminate certain flavors). A new
alcohol oxidase enzyme may facilitate o^tygen absorption in food packages,
increasing shelf life. Also enzymes are being developed to facilitate
measurement of such product attributes as alcohol content, and facilitate
quality control in food production and processing. Genetic engineering now
offers the opportunity for more than one enzyme to be combined with other
materials to reduce processing steps and time (e.g., a genetically engineered
yeast strain with an enzyme added to simultaneously produce alcohol and reduce
the carbohydrates in light beer production, thus speeding up the brewing
process).
The fermentation process is the other area where some significant
biotechnology innovations may emerge in the next five years. Some examples
derived from an expert panel of food technologists are listed in Table 1.
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Table 1. Dates of Technical Feasibility and Commercial Availability for
Most Frequently Identified Targeted Biotechnology Areas
Area
rDNA to Produce Vaccines
Growth Hormones^
Monoclonal Antibodies
(MABs) to Diagnose Animal
Disease or Conditions
Interferons/Interleukens
Other Probes/Vectors^
Genetic Modification
(Somatic and Germ Line)
MABs to Control Large
Scale Disease Problems
No. of
Citations^
186
134
106
65
63
60
56
Augmentation of Feed Additives A2
Antibiotics, Drugs 37
Estimated Mean
Range of Technical
Feasibility
1987-88
1986-87
1986-87
1987-88
1986-87
1988-89
1988-89
1987-88
1987-88
Estimated
Mean Range
for Commercial
Availability
1989-91
1989-91
1987-88
1989-91
1988-89
1993-94
1989-91
1989-91
1989-91
^Includes both general citations of the target area, and citations of specific
products vithin the target area.
l^Includes the two most frequently identified products - Bovine Growth Hormone,
Porcine Growth Hormone.
•^Other Probes and Vectbrs include a variety of disease technologies, including
rDNA probes to diagnose disease; regulation and enhancement of the ^une
system; and specialized assays such as ELISA (Enzyme-Linked Immuno Absorbant
Assays).
Source: Emerging Developments in Veterinary Biotechnology, U.S. ^nd Drug
Administration. U.S. Department of Commerce. National Technical
Information Service CPI85-222379), July 1986.
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Molds, yeast, or bacterial fermentation processes now provide ™any of our food
ingredients (e.g.. vitamins, amino acids, enzymes, antioxidants). in add.txon
to the consumer products that we more typically associate vith fermentatxon-
heer, sourdough bread, cheese and yogurt, etc. With increased mxcrobxal
densities and yields from fermentation processes that are now feasible, many
.ore products from fermentation will be potentially profitable con^ercial
products, not just pharmaceutical products, cosmetics and colors that sell at
extremely high values per pound (such as Japanese production of royal purple
pigments via fermentation).
one of the primary near-term applications of biotechnology is in
improving starter culture (bacteria) efficiency; the light beer technology
mentioned above is one example, while cheese cultures are another prxme area
of new product development. Several strains of microbes in
regulatory clearance stage enhance flavor development in cheese production (a
novel lipase enzyme has recently been introduced commercially), speed up the
ripening process, or serve as inhibitors to viruses or other pathogens which
can develop in the production process. Genetically engineering pathogenic
resistance into the culture organisms could inhibit such problems as listeria
or salmonella infections prone to develop in cultured consumer products.
Other fermentation processes (meat, vegetables, dairy) are being
developed: stabilized lactose fermentations, purer starter cultures in meat
fermentations to reduce staphylococcus infection outbreaks; and novel
procedures to improve nutritive quality, product texture, or produce new
flavor enhancers, sweeteners, natural flavors, or acidulants. For example,
the peptide thaumatin which has extreme sweetness has been isolated from West
African fruit. If some aftertaste problems can be solved, genetic engineering
lA
.h.t ,.p.id. i... ^ •"""
result in another low calorie natural sweetener.
PRODUCT INTRODUCTIONS
o< ci™- -.-y- "
li^ly ~ "• """"
a..... »Po..r. o.n b. li.l..d. - «" l-"-" " »"•'"=• *"
.u,pl, o. ...<1 ™b. •'• »" "•"*
..otai,... « ..=1. "»• "
n„U,, a. r.». d.v.lop™... i. —.1.7 -V"-
anti-Viral prophylactic products could extend to the animal veterinary market
a few years. (These and other development possibilities noted xn the F
,,S5-1986 survey are listed in Table 2). Anti-virals like alpha interferon or
similar anti-bacterials may have possibilities in mastitis or shipping fever
control. in^unity system boosters, like interleukin-2 in combination w.th
other products, could find new anti-bacterial uses in the livestock and
. . -p ar,i--i-virals anti-bacterials, or growthpoultry industries. Microxnjection of anti virals. an
r• oool -i s nearine commercialization in thehormones into chick embryos (in the egg)
poultry industry.
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Table 2. Some Possibilities for Microbial Production of Actual
and Potential Food Ingredients
Ingredient Function
Acetic acid Acidulant
N-acetyl tripeptide Immune enhancer
D-arabitol Sugar
Beta-carotene Pigment
Chrysogenin Pigment
Citric acid Acidulant
Citronellol Fruity flavor
Curulan Thickener
Diacetyl Buttery flavor
Dextrans Thickeners
Emulsifier Emulsification
Fatty acid esters Fruity fragrances
Gamma decalactone Peach fragrance
Geraniol Roselike fragrance
Glycerol Humectant
Glutamic acid Flavor enhance;:
Lactic acid Acidulant
Leucine Amino acid
Lysine Amino acid
Mannitol Sugar
Methanol Flavor
3-methoxy-3-isopropyl- Potato odor
pyrazine
Methylbutanol Malt flavor
3-methyIbutylacetate Banana fragrance
Monascin Pigment
Nisin Antimicrobial
5-nucleotides Flavor enhancers
6-pentyl-2-pyrone Coconut fragrance
L-phenylalanine Aspartame precursor
Proline Amino acid
Sesquiterpenes Fruity fragrance
Surfactant Wettability
Tetramethylpyrazine Nutty flavor
Thermogelable Thickeners
polysaccharides
Vitamin B-12 Vitamin
Xanthan gum Thickener
Xylitol Sweetner
Source: Food Technology, January 1988.
Producing Organisms
Acetobacter pasteurianus
Bacillus cereus
Candida diddensii
Blakeslea trispora
Penicilliujn chrysogenum
Aspergillus niger
Ceratocystis spp.
Alcaligenes faecalis
Leuconostoc cremoris,
Streptococcus lactis
Leuconostoc mesenteroides
Candida lipolytica
Pseudomonas spp.
Sporobolimyces odorus
Klujn/eromyces lactis
Bacillus licheniforrais
Corynebacterium glutamicum
Streptococci and
lactobacilli
Brevibacterium
1act0ferraenturn
Corynebacterium glutamicujii
Torulopsis mannitofaciens
Pseudomonas putida
Pseudomonas perolens
Streptococcus lactis var
maltigenes
Ceratocystis moniliformis
Monascus purpureus
Streptococcus lactis
Corynebacterium glutamicum
Trichoderma viride -
Bacillus polymyxa
Serratia marcescens
Lentinus lepideus
Bacillus licheniformis
Bacillus subtilis,
Corynebacterium glutamicum
Argobacteriumm radiobacter
Propionibacterium
Xanthomonas campestris
Torulopsis Candida
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LIKELY INNOVATIONS IN THE LATE 1990s
Coranercial product introductions from biotechnology are likely to
increase in number and importance five to ten years from now.
Growth stimulants for livestock and poultry (produced via recombinant DNA
technology) will develop further as increased scientific knowledge of the
hormonal checks and balances in commercial animals improves first generation
products (especially the somatotropins). and bring on the next generation of
growth regulators or stianulators. This second wave includes the growth
hormone releasing factor, which causes the animal to produce more of its own
growth hormone, somatomedins and insulin growth factors (possibly more direct
growth stimulants). and somatostatin inhibitors (which release the brakes on
growth hormone effectiveness). In addition to these growth promotants. the
luteinizing hormone releasing factor may become available, fostering the
growth and leanness benefits of male sex hormones (perhaps in beef cattle or
swine) without their present disadvantages.
Afew experts forecast that the introduction of growth hormone genes into
farm animals may become a commercial reality toward the end of the next
decade, replacing injection and implantation of growth stimulants. The
initial targets of research are on the growth, feed efficiency, and improved
fat and lean carcass composition effects of the growth hormones, ,and the
discovery of genetic bases for disease resistance. Genes stimulating growth
hormone production are the most likely possibility for the first coMnercial
transgenic farm animals, especially in swine where the benefits from long term
somatotropin injections is so dramatic. The recent court ruling that novel
transgenic animals can be patented reduces uncertainty about whether
innovators will be able to capture a'share of the gains from transgenic animal
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research and development. However, interesting questions remain about pricing
methods and royalty payments for industries new to such procedures.
Transgenic plant and microbial product introductions are 'likely to be
much more frequent in the last five years of the next decade. Plants now
undergoing field testing involve single gene transfers for herbicide
tolerance, insect resistance, and viral resistance, or single gene deletion
for the ice-minus bacteria. Bioinsecticides are now based on the Bt
toxin. Both plant and microbial products are likely to involve combinations
of genes (or toxins) for a much broader array of effects. Multiple gene
transfers will be needed to achieve: desired significant change in leaf design
for more effective photosynthetic activity and moisture retention capability;
tolerance of moisture and temperature stress; improved standability; and
increased yield in major agronomic crops. These more complicated targets for
biotech research may begin to be realized in the late 1990s in some large
volxane grain and oilseed crops.
Value-added food products using genetic engineering, cell culture,
fermentation and enzyme technology could become much more prevalent in
processing and the consumer market in the late 1990s. Industrial or
pharmaceutical products could be produced using agricultural crops or farm
animals as the factory (e.g., drugs produced in tobacco or milk). The
fragrances, flavors, and colors produced with transgenic plants or microbes
should be noteworthy. But, bigger steps will be involved in manipulating oil
yields and the fatty acid composition of soybeans, the protein levels and
amino acid composition of major grains, and the starch composition in products
like corn and rice. Consider, for example, the suggestion of one expert:
Incorporating a gene for the omega-3 fatty acid from fish (considered
desirable for persons with high cholesterol) into a major oilseed like the
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soybean, sunflower, or rapeseed. The nutritional, taste, textural, and
shelf-life characteristics of major food products could be affected in
significant ways in the late 1990s, though the regulatory and biological time
lags for transgenic plants and, especially, animals probably will delay their
major economic impacts until the 21st century,
IMPLICATIONS FOR AGRIBUSINESS
Currently, the most noteworthy biotechnology innovations likely to be
marketed in the next decade are in plant and animal production. Their impact
will be felt more intensely and sooner by agricultural producers and
agricultural input suppliers, though a few developments will impact processors
and merchandisers significantly. If technological change in agriculture in
areas other than biotechnology continues at or near its recent pace, the
incremental effects of biotechnology probably will accelerate the rate of
technological change. These developments will place increased demands on
managers in keeping informed about new developments, and capitalizing on, or
coping with, the implications of these new technologies. Effective strategic
planning will become more important and more difficult due to unanticipated
direct or indirect effects on agricultural producers and agriculturally
related industries.
Agricultural biotechnology innovations lead to: 1) production
expansion, 2) cost reduction, 3) risk reduction, 4) product quality
improvement, or 5) new product development. Most developments will involve
more than one of these effects. For example, porcine somatotropin may reduce
costs, improve product quality, and increase lean meat production per pig.
Impacts that lead to increased production, improved profitability, or reduced
risk will shift the individual and industry supply curves to the right, while
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enhanced product quality or new products for consumer or industrial markets
will shift their respective demand curves, and the associated derived demand
curve at the farm level. Demand curves for related products (substitutes or
complements) may shift as well in domestic arid international markets.
Early adopters will enjoy better profits from yield increases or cost
reductions, or less risk in the short run. Their individual positive supply
response to an improved situation will shift the industry supply curve,
reducing prices. Nonadopters of the technology will be immediately adversely
affected. If they leave the industry the adopters' aggregate supply response
and price impact would be partially mitigated. But, the temporary profit
surge enjoyed by the adopters will be dissipated in the long run through the
industry supply response, leaving the long run equilibrium profit level
unchanged. Consumers, however, may benefit by getting more and paying less,
especially in markets with inelastic demand for food.
The effects of a product quality improvement or a new product are
somewhat more difficult to predict. Theoretically, again, early adopters will
be short-term winners. However, in the real world so much depends on how the
new development is commercialized and accepted by the public.
Consumers' attitudes are crucial, for without consumer acceptance of the
new or changed biotech product, it won't sell and the new technology won't be
adopted. Promotional costs may be high for initial consumer product offerings
from biotechnology, especially if there has been any adverse publicity about
the development. Thus, general public attitudes toward biotechnology and its
associated risks in food products, the work place, and the environment are
important determinants of the costs involved in product development, getting
regulatory approval, the actual use of the biotechnology, and the
merchandising of the resulting agricultural products.
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Agricultural producers
As with all new technologies in competitive industries, the first
adopters would be expected to get a share of the initial benefits. New
technologies offered by a biotech company should be priced attractively enough
to provide economic incentive to farmers so that a relatively high market
penetration rate is stimulated. The potential revenue, a combination of the
volume sold and the unit price, must be sufficiently attractive economically
for the biotechnology company to develop and market the product.
While biotechnology products tend not to be as capital intensive as, say,
mechanical innovations, some products may require changes in operating
practices. Some of the more sophisticated farm managers are more likely to be
early adopters. Because they would also tend to be the larger farm
operations,, the trend toward larger farm size could be accelerated. At least
for some biotech developments, it will be the larger farms which will enjoy
more of the benefits of early adoption.
Targeted biological pest controls or growth promotants in plant
production may soon be substituted for some agricultural chemicals. These
could be more environmentally friendly and may offer reduced health risk for
farm workers.
Genetic engineering of plants for herbicide resistance may lead to seed
and chemical technology package deals and thus a link between two formerly
distinct input markets. Future biotechnology developments may lead to each
seed variety having strains resistant to a particular broad spectrum
herbicide. In this sense the products will become more differentiated even as
the market becomes more integrated, potentially providing a significant
competitive advantage to both the companies producing the differentiated seed
and the related herbicide.
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As improved consumer or processing product characteristics are developed
with biotechnology, the developers may elect to license that technology to
many merchandisers or they may internalize the merchandising xn hopes of
capturing increased profits. This may mandate increased control of the
production process by merchandisers; vertical integration or contract
production may become more prevalent. If a new product is clearly better, and
contract production is the only way to stay in business, some independent
farmers and ranchers may have to switch rather than fight a losing competitive
battle.
A few new products from biotechnology may change the climatic or stress
tolerance of a crop or its susceptibility to insects or diseases found in
certain areas. These developments could shift the regional comparative
advantage for the affected crops. 'As production shifts regionally and the
local crop mix changes, direct and indirect losses occur, while opportunities
are created elsewhere. For example, a specialized processing facility may
become remote from its raw product source.
Increased feed efficiency in the livestock sector due to biotech advances
may depress demand for feed grains and. to a lesser extent, oilseed meals,
if overall demand for animal products doesn't increase significantly. If crop
yield increases also continue, or accelerate, feed grain prices could decline.
Similar productivity improvements also may occur in other crops, which may not
be matched by equivalent market expansion. Since the biotechnology
innovations reaching the market in the next decade appear more likely to
expand supply than increase demand in the next decade, this could lead to
relatively less demand for resources like land to be devoted to agriculture,
and prices .could be under downward pressure if some agricultural land has to
shift to new, second-best uses.
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Input supply industry
There are two important trends within the biotech industry; both imply
greater concentration.. The first relates to "biotech boutiques" begun by
entrepreneurs a decade or more ago that have been unable to generate an
adequate cash flow. Some of these firms unable to float new capital offerings
have developed contract research linkages with other larger food product or
agricultural chemical, seed, or pharmaceutical companies to fund their
undercapitalized primary research activities. Others have been acquired
by larger companies as an investment vehicle, or as a way to have an in-house
biotechnology research group.
A second trend involves other contractual linkages or joint efforts
between biotechnology firms and tj^^es of input marketing companies with well
developed distribution systems to farmers. Since research entrepreneurs may
lack the expertise and capital required to develop regional or national
marketing systems, their linking with other firms in joint development-
marketing schemes allows them to exploit economies of scale and previously
sunk costs in a successful marketing operation. Also, companies strong in
biotechnology research use mergers or acquisitions as a way to capture more
fully the economic benefits from their research. The seed industry
has seen significant acquisition activity over the last several years,
as some investors attempt to capture more of the benefits from recombinant
germ plasm for the large-volume commercial crops. Thus, a number of
biotechnology ventures have lost some or all of their independence, as
contractual or ownership vertical integration links are being forged in the
agricultural input supply industry.
Both genetic engineering of plants for insect and virus resistance and
biological controls for plant pests appear likely to reduce use of some
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chemicals. Herbicide resistance engineered into plants may displace the use
of certain chemicals and may also displace labor in some labor-intensive crops
like tomatoes. As input displacements may occur, input suppliers may find
themselves facing an unanticipated competitor.
The product lines of farm input supply companies will undoubtedly
expand: new diagnostic tools like monoclonal antibodies, new vaccines and
immunity system enhancers; differentiated seeds engineered for particular
herbicides, pests, or viruses, or other product or yield characteristics; and
new animal growth promotants.
If commercial farm animal productivity is significantly improved, with
less feed required per unit of consumer product, the feed industry could be in
line for a significant adjustment. More sophisticated ration management by
larger operators, with a different mix of feed stuffs and services required
for potentially fewer animals in some species all this may lead to
significant adjustments in the industry.
More complex technology requires more sophisticated management, which may
lead to larger farms. As these farms deal with their input marketing firms,
more direct marketing with an increasingly sophisticated sales force may be
required by the feed, seed, animal health, and related industries serving
farmers and ranchers.
Food processing and merchandising
The short-term effects of biotechnology appear to be improved efficiency
in food processing enzyme and fermentation technology. Greater use of
fermentation or cell cultures for production of relatively high cost colors or
flavors may occur relatively soon, but significant changes in other food
product characteristics (and corresponding product differentiation in food
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processing and merchandising) due to biotechnology will occur more slowly.
The first impact will be efficiency gains and cost advantages for some food
processors. Later will come more noticeable changes in consumer product
characteristics. Changes at the processing level could have significant
impact on procurement methods for raw materials (more contract production and
vertical integration) to maintain control. In addition, more highly
differentiated products may involve increased segregation in the handling and
distribution systems, more sophisticated grading and quality control systems
(especially where product differences aren't visually apparent), and more
branded products supported by advertising and promotion.
As we have noted, consumer acceptance could be a significant problem in
these early stages of biotechnology. Public concerns about BST have certainly
prompted a significant corporate education effort long before it is actually
marketed. Similar steps may be necessary in other areas as new products are
developed.
Conclusion
The biotechnological revolution is in its very early stages. It promises
much, but, as with any revolution it will bring about many changes. While the
pace of change will be slow initially, which may ease the adjustment process
to some extent, the pace of change will quicken. While there will be
significant benefits, some adjustments will be required that clearly will have
costs attached for some agribusiness firms.
Differing national regulatory environments around the world will affect
where and how fast the products of biotechnology will appear. Just as the
early adopters gain individually, so may the early-adopting nation.
Regulatory differences between nations could determine who wins and who loses
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internationally in the new dynamic environment of the biotechnology
revolution.
For effective strategic planning, agribusiness firms need to develop an
early warning system for those biotechnology innovations here and abroad
which may provide significant opportunities or problems. Otherwise,
opportunities will be seized by competitors, and adverse shocks may not be
absorbed or countered effectively.
University research and extension programs can help ease the inevitable
transition by educating the public and the agribusiness sector regarding
biotechnology, its promise and problems, and providing an early warning system
on forthcoming innovations and their implications.
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